Hypothetical clinical cases were used to investigate transfusion-related decision-making. Three red cell, three fresh frozen plasma (FFP) and three albumin transfusion decision cases were administered by questionnaire to 228 medical staff The transfusion decision triggers were identified and comparisons made between resident and specialist groups and between Melbourne and Sydney participants.
relate to risk perception, which depends on knowledge and experience, of acute, delayed, infective and immunological morbidity compared with the risks of withholding that transfusion. Certain clinical and nonclinical factors influence this risk perception: the degree of exposure to transfusion medicine in the medical curriculum and at the clinical interface, the number of years of experience, the practice style of the medical environment, the degree of interventionism and the receptiveness to new information. Additional factors such as peer pressure, patient preferences, perceptions of resource availability and cost may also have a marginal impact. 913 The aim of this study was to assess transfusion decision making. Nine hypothetical cases were put to medical staff in an attempt to evaluate red cell, FFP and albumin transfusion triggers. Copies of the full study questionnaire are available on request. Appendices 1-3 have the salient case history details.
METHODS
To assess transfusion triggers and current transfusion practices, 228 medical staff participated in a case scenario questionnaire. Participants were divided into resident (n = 98) and specialist (n = 130) groups and are shown in Table 1 . The Sydney participants (n = 120) Anae$[hesiu and Intensive Care, Vol. 21 provide vertical information in a single teaching hospital whereas the Melbourne participants (n = 108) came from several different teaching hospitals in the Melbourne and Geelong area. The survey was presented in 1989 either as a written or verbal questionnaire without interpretation by the inteviewer. Nine scenarios were presented; three involved red cells transfusion triggers, three FFP transfusion triggers and three albumin transfusion triggers, either as concentrated 25% albumin or 5% stable plasma protein solution (SPPS). The respondents were asked to indicate at what point they would initiate a red cell transfusion (cases 1-3), FFP transfusion (cases 4-6) and albumin transfusion (cases 7-9).
RESULTS

Red Cell Transfusion Triggers Case 1
In an asymptomatic 53-year-old man, with an intermittently bleeding peptic ulcer and a progressively falling haemoglobin (Hb), the transfusion decision was predominantly made between Hb 99 gll and 89 g/l; 18070 to 56% of respondents would respectively initiate a red cell transfusion. The presence of symptoms consistent with anaemia or respiratory co-morbidity raised the haemoglobin threshold significantly and the transfusion decision was made correspondingly earlier. For example, at Hb 109 gll, 22% would transfuse a symptomatic patient and 25% would transfuse a patient with a history of chronic airways disease. At this Hb, less than 5% of respondents would transfuse an asymptomatic patient ( Figure 1 ).
Different transfusion decision triggers were noted between the participants. For example, at a haemoglobin of 99 gll, surgeons were four times more likely to transfuse asymptomatic patients than physicians or anaesthetists. At all haemoglobin levels the Sydney specialist group was more conservative in the use of 
Case 2
In the context of a low preoperative haemoglobin in a 66-year-old man, admitted for elective resection of carcinoma of the colon, 24% of the medical staff would transfuse at Hb 104 gll, 71% at Hb 94 gll and 88% at Hb 84 g/l. Three days after uneventful surgery, 10%,52% and 85% of respondents respectively would initiate a red cell transfusion in this patient ( Figure 2 ). In this stable patient, in the recovery ward with a Hb 100 gll, one third of the respondents would transfuse red cells after documented intraoperative blood loss of 750 ml. This rose to 66% of respondents initiating a red cell transfusion after an estimated 20% blood volume loss has been documented ( Figure 3 ). 
Case 3
In an elective caesarean section, 50070 of the respondents would transfuse preoperatively at Hb 90 g/I; 42070 would transfuse this patient postoperatively at this Hb. Similarly, at a Hb of 85 g/I, 76070 and 67070 of respondents would transfuse this patient preand postoperatively. Once again, Sydney specialists were the most conservtive, with 41070 transfusing at Hb 90 g/I (preoperatively) compared with 62070 of Sydney residents and 60070 of all Melbourne respondents (P < 0.05).
Gender did influence the transfusion decision; for example, in the preoperative period, 24070 and 71070 of respondents would transfuse a male patient (Case 2) at Hb 104 g/l and Hb 94 g/l. In comparison, in a female patient (Case 3), 7070 and 26070 of respondents would have transfused the patient at a Hb 105 g/I and 95 g/l respectively. This different transfusion trigger reflects the lower normal female Hb range and haemodilution considerations of pregnancy and is at variance with the respondents' earlier statement that the transfusion trigger would not be lower in female patients.
In a red cell transfusion decision, the haemoglobin, symptoms of anaemia, the presence of co-morbidities or surgery, the period of hospitalisation, documented blood loss and gender appear to be considerations in the decision to transfuse red cells.
FFP Transfusion Triggers
Case 4
In the management of a warfarinised patient with intermittent epistaxis, 9070 of respondents would have administered FFP at an International Normalised Ratio (INR) of 2.0 and 15070 would have transfused FFP with an INR of 3.0. There were no differences in FFP transfusion triggers between the groups of participants in this case.
Case 5
This scenario explored the option of administering FFP with increasing intraoperative red cell transfusions in a young man involved in a motor vehicle accident. After transfusing 4, 6, 8, and 10 units of red cells, 12070, 39070, 64070 and 72070 of all respondents would have administered FFP (Figure 4 ). Both Melbourne groups were more conservative of FFP administration when compared with Sydney groups. For example, after the transfusion of six units of red cells, 37070 Melbourne residents and 25070 Melbourne specialists compared with 70070 Sydney residents and 40070 Sydney specialists would transfuse FFP. The different responses between residents and specialists, Melbourne and Sydney groups are all statistically significant at P < 0.05. No. of Red Cell Units Transfused 
Case 6
In the context of disseminated intravascular coagulopathy in a 28-year-old primipara requiring urgent caesarean section for abruptio placenta, 75070 of Sydney residents, 54070 of Melbourne residents and 43070 of both specialist groups would have transfused FFP. The regional differences in transfusing FFP were significant between Sydney and Melbourne residents and between the two Sydney groups (P<0.05).
Albumin Transfusion Triggers Case 7
The management of resistant ascites in a 43-year-old woman was the first albumin transfusion decision case history. With a serum albumin of 26 g/I, 13 070 respondents would give albumin concurrently with diuretic therapy and 29070 would transfuse albumin only after 48 hours of unsuccessful diuretic therapy: 90070 would have used the concentrated albumin (25070) preparation. In the clinical situation of a lower serum albumin (18 g/l) and failed diuretic therapy, 68070 would have transfused concentrated albumin and an additional 10070 would have transfused SPPS. With an uneventful paracentesis (1,000 ml, 26 g/l serum albumin), 26070 of respondents would have transfused concentrated albumin and 6070 would use SPPS. If, however, a 2000 ml paracentesis had been performed with subsequent hypotension, 52070 would initiate transfusion with SPPS: an additional 41070 would use concentrated albumin and 14070 would transfuse both products ( Figure 5 ). There was reasonable concordance b~tween resident and specialist groups in both cities: however, twice as many Melburnians would have transfused albumin at commencement of diuretic therapy and at 48 hours (P < 0.05). 
Case 8
The participants were asked to decide on preoperative albumin or SPPS administration in the presence of hypoproteinaemia: 4070 would transfuse SPPS or concentrated albumin pre-or intraoperatively. However, with progressive fall in urine output to 33 mllhour, 25 mllhr, 17 mllhr and 8 mllhr, 6070, 18070, 52% and 66% of the respondents respectively would administer albumin ( Figure 6 ). Nine per cent would use concentrated albumin and 91 % would have used SPPS. The different responses between the groups were not statistically significant. In a follow-up question, 6070 of respondents would transfuse SPPS or concentrated albumin with a urine output of 30 mllhr. With a continued fall in urine output to 18 mllhr, 8070 would give concentrated albumin and an additional 58070 would transfuse SPPS. There were no significant differences between the Sydney-Melbourne and resident-specialist group responses in the transfusion triggers for SPPS or 25070 albumin. In both cases 8 and 9, the majority decision to transfuse SPPS or concentrated albumin was precipitated by a fall in urine output to 17-18 mllhour.
DISCUSSION
The results of this study have demonstrated the likely red cell, FFP and albumin thresholds and transfusion decision triggers in teaching hospitals in both Sydney and Melbourne. The ideal transfusion trigger or the optimum threshold for the initiation of transfusion therapy is unknown. 8 -14 It is nonetheless useful to know when medical staff, faced with transfusion decisions in their day-to-day hospital-based practice, would decide to transfuse. Comparisons can then be made between groups and individuals. Different trends are apparent both on a regional basis and more significantly, between resident and specialist staff. Different responses between speciality groups and their type of clinical practice were more limited in this study but may for example, reflect a more interventionist approach by some surgical units. 10, 11 It is difficult to be dogmatic about what is an appropriate red cell, FFP and albumin transfusion as the threshold prompting the decision to transfuse will vary in different clinical circumstances. Nonetheless, consensus statements should serve as a useful guide. 1, 3 There has been a recent change in patterns of blood usage,4-7 with for example, an increase in the use of predeposit autologous blood 13 and a reduction in the usage of FFP. 15 -17 In some institutions, proposed transfusion management is reviewed before it occurs and is only allowed to proceed if it is appropriate to the clinical circumstances. 6 Such strategy allows for prospective evaluation of component use as well as oneon-one educational opportunities. 6 This gatekeeper role leads to a reduction in blood component use and stimulates a re-examination of transfusion habits and patterns of care. 7 It is no longer valid to simply transfuse red cells when the haemoglooin falls below a certain numerical value, eg the "10/30" rule 1 as the threshold may be different in certain surgical contexts or in the face of co-morbidities.
The most important factor in red cell transfusion decision is the haematocrit or haemoglobin. 18 Our study also identifies symptoms of anaemia, surgery and the presence of comorbidities as important factors which influence the red cell transfusion decision. Co factors in the transfusion decision also include the specific phase of hospitalisation, eg pre-, intraand postoperative periods; the rate of change of haematocrit; the extent of intraoperative blood loss; changes in vital signs and ongoing postoperative blood loss.
In our study the majority of respondents stated that gender did not influence their decision to transfuse red cells, yet, when presented with a different case in a female patient, a lower haemoglobin was acceptable before the decision to transfuse red cells. It is surprising that the majority of respondents transfusing preoperatively in the female patient (Case 3) would also transfuse at the same haemoglobin in the postoperative context. This is at variance with Friedman et al whose study found no difference in the transfusion trigger between male and female surgical patients and that all red cell transfusions were initiated at a predetermined level. 18 This was reflected in the almost equal transfusion rate in male and female patients with intraoperative bleeding and a higher transfusion rate in female surgical patients with postoperative bleeding compared with their male counterparts. These transfusions however, were stopped at a lower ceiling haemoglobin and hence female surgical patients received fewer units of blood. Similarly the patient's age may have influenced the red cell transfusion decision 18 as disease severity may be more significant in any elderly group.
In the plasma transfusion decision, the prophylactic and prescriptive use of FFP, e.g. in a patient requiring a massive blood transfusion, must be made with consideration of other factors such as the presence or absence of underlying liver disease, the patient's medication history and coagulation laboratory results rather than just when a certain number of red cell units have been transfused. 19 Our study identifies the number of red cell units transfused as a major decision cofactor in FFP administration and reflects an area where education should be targetted. Other identifiable factors included abnormal coagulation test results and clinical circumstances; for example, in Case 4, given that the patient had been on warfarin for three months after a deep venous thrombosis, the transfusion of FFP would be considered inappropriate. At both INR the question of ceasing warfarin should have been raised a:nd a more local cause suspected for the epistaxis.
Previous studies have also surveyed transfusing medical practitioner beliefs by using a series of brief vignettes. 4 Avorn et ai, in a 45 minute interview questionnaire to 122 physicians, surgeons, anaesthetists and house officers, asked what clinical information was considered critical to the transfusion decision. The authors attempted to assess the respondents' transfusion risk perception to determine their position on the interventionist/non-interventionist practice gradient. Clinical knowledge, level of interventionism and other non-medical factors were all important in influencing the decision to transfuse. Similarly, organisational and attitudinal factors, which may be independent of clinical knowledge, were also important in shaping clinical transfusion decisions. 4 Hypothetical case responses however, have not been consistently correlated with actual clinical performance. 12 The lack of patient-doctor contact in these hypothetical cases precludes an assurance that the medical participants would actually do what they say they would. As such, these patient management cases really measure a technical rather than an actual judgement but nonetheless, still provide a consensus view. Large interregional differences in the intensity of blood transfusion have been identified in our survey. These have been previously reported and appear to persist even after consideration of specific patient demographic and case mix data. 14 A complementary insight into transfusion practices can be provided by reviewing the blood product issues per 1,000 population in New South Wales and Victoria (Table 2) . 20 There is a correspondence between the red cell and FFP transfusion decision triggers and the red cell and FFP issues in both States. For example, the Victorian red cell issues exceeded that of New South Wales by 15.7070 and can be interpreted as supportive of earlier red cell transfusion decisions by the Melbourne group. In contrast, FFP issues in New South Wales exceeded that of Victoria by 18.8070 for the same period which perhaps reflects earlier transfusion of FFP in Sydney. Geographic differences in blood product orders are immediately apparent but caution in interpretation is required as some differences between transfusion requests and usage exists and some wastage, especially pertinent to red cell issues, results. The combined albumin and SPPS usage, with Victorians issuing 60.2070 more albumin and SPPS than their New South Wales counterparts, however, was not really reflected in our survey; Melburnians, however, were twice as likely to have transfused albumin for the management of a patient with ascites.
It is possible that the regional differences in transfusion responses relate to the presence or absence of local measures such as hospital transfusion committees, active transfusion medicine specialists, transfusion education programs and access to and availabilitty of blood products. Prescriptive control on the use of blood and blood products, for example, the vetting of all platelet or FFP transfusion requests by the hospital's blood bank or medical director, may also have a marginal impact on hospital transfusion practices,6 and computer-based 21 or manual 22 approaches, using an algorithm-audit-inquiry process, can also be used to validate transfusion practices in real time rather than retrospectively. 4-7.1517 These are more likely to influence transfusion practices than large group lectures. Individualised sessions, print material 4 and one-on-one educational opportunities,6 targetting higher transfusion trigger subgroups, are more effective. Administrative intervention,4.21.22 the establishment of transfusion guidelines 1-3.15-17 and the promulgation of transfusion morbidity and mortality data 5 are also of use.
Why resident staff would have initiated transfusions earlier than their comparable specialist group is also unresolved. Knowledge of transfusion morbidity and mortality may be relevant especially when coupled with experience. As a group, the residents' transfusion practice style may reflect a more interventionist approach with errors of commission preferred to errors of omission. Such an approach may be reinforced by the hierarchical relationships between medical and surgical units and their resident staff and may reflect more concern about the negative outcomes, for patient and self, due to the withholding of a blood transfusion, rather than with the potential reactions associated with administering the units of blood. There may be a lower perception of transfusion risk in these resident groups which may reflect an inadequate medical school curriculum or limited clinical experience.
The balance of risk and benefit should be considered in all transfusion episodes and various strategies must Anaesthesia and Intensive Care. Vol. 21, No. 2, April, 1993 be co-developed at both under-and postgraduate levels to increase the baseline knowledge of transfusion medicine and to improve the rationale behind transfusion decisions.
